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Abstract The protective effect of lysozyme-galactomannan or 
lysozyme-palmitic acid conjugates orally administered to carp, 
Cyprinus carpio L. was investigated using a virulent strain of 
Gram-negative EdwardsieUa tarda isolated from an infected fish. 
Lysozyme-galactomannan conjugate was prepared through 
controlled Maillard reaction. Lysozyme-palmitic acid conjugate 
was prepared through base-catalyzed ester exchange using N- 
hydroxysuccinimide ster of palmitic acid. The conjugates 
provided substantial protection to carp infected with a Gram- 
negative bacteria f'Lsh pathogen E. tarda NG 8104. Lytic 
activities of lysozyme conjugates with galactomannan and 
palmitic acid were about 80 and 71% of native lysozyme using 
Micrococcus lysodeikticus as a substrate. Feeding with lysozyme 
conjugates, for 8 days, significantly enhanced fish protection 
against E. tarda infection. The survival rate was 30% for 
lysozyme-galactomannan conjugate treated fish and 20% for 
lysozyme-palmitic acid conjugate treated fish after 6 days 
cultivation while all control fish died within 3 days. On the 
other hand, a recovery rate of 40% after 6 days was observed in 
the fish group that were fed lysozyme-palmitic acid conjugate 3 
and 2 h before and after E. tarda challenge, respectively, and for 
6 consecutive days. The results of this work show the possibility 
of utilizing lysozyme conjugates with galactomannan or palmitic 
acid as a therapeutic for infection in fish. 
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1 Introduction 
Antimicrobial activity of lysozyme is limited to Gram-posi- 
ti ee bacteria. In mammalian and fish cells, lysozyme plays an 
iJ~aportant defense role in the earlier stage of bacterial infec- 
ti,gn by enhancing the phagocytosis of bacteria [1-3]. In an 
effort to expand the antibacterial activity of lysozyme to 
Gram-negative bacteria, lysozyme derivatives having bacteri- 
c,Aal activity against Gram-positive as well as Gram-negative 
bacteria were prepared by covalent attachment of polysac- 
cilarides or fatty acids to lysozyme lysyl residues [4-7]. The 
aatimicrobial effects of lysozyme conjugates against Gram- 
n~gative bacteria were associated with the degradation of 
t]~e outer membrane in the bacteria and subsequent lysis of 
the peptidoglycan i the cells. The safety of lysozyme conju- 
gates prepared through controlled Maillard reaction has been 
rt'ported [8]. 
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Edwardsiella tarda (Edwardsiellosis) is a serious problem to 
the farming industry because the disease often occurs in fish 
grown in farming ponds. E. tarda, a Gram-negative bacteria 
belonging to the family of Enterobacteriaceae causes disease 
in fish. E. tarda NG 8104 was isolated, for the first time, from 
a flat-fish as a virulent pathogen in Japan. The use of anti- 
biotics to control the bacterial infection in fish is a concern 
because it promotes the growth of drug-resistant bacterial 
strains [9]. Lysozyme is widely distributed in fish at their 
body, surface, skin, gill, intestinal tract, and serum as a pro- 
tection factor against bacterial infection [2]. The physical anti- 
microbial action of lysozyme is suitable for use in aquaculture 
because it may provide an effective approach to prevent bac- 
terial infection in fish without concern over residual antibio- 
tics in the fish. The purpose of the present paper was to in- 
vestigate the protective effect of orally administering 
lysozyme-galactomannan or lysozyme-palmitic acid conju- 
gates to fish against a virulent strain of E. tarda. 
2. Materials and methods 
2.1. Materials 
Mannase hydrolysate of guar gum (galactomannan, verage mole- 
cular weight of 15000) was supplied by Taiyo Chemicals Co.(Mie, 
Japan). Palmitic acid was obtained from Sigma Chemical Co.(St. 
Louis, MO). Microcoecus lysodeiktieus cells for lysozyme assay was 
from Wako Pure Chemicals, Tokyo, Japan. Bactotrypton and bac- 
toyeast extract were from Difco Laboratories (Detroit, MI). Heart 
infusion medium and MacConkey medium were from Nissui Seiyaku 
Co., Tokyo, Japan. Commercial fish pellet was from Nippai Shiryo 
Co., Tokyo, Japan. All other chemicals were of analytical grade. 
2.2. Preparation of lysozyme-galactomannan conjugate 
Lysozyme was purified from fresh egg white at pH 9,5 in the pres- 
ence of 5% sodium chloride and recrystallized five times. Galactoman- 
nan was dialyzed against deionized water for 2 days at 4°C. Lysozyme 
and galactomannan, in a weight ratio of 1 : 1, were dissolved in water 
and freeze-dried. Lyophilized mixture was spread over a petri dish and 
incubated at 60°C for 2 weeks at 79% relative humidity as previously 
described [4]. The resulting powder was stored at 4°C and used as 
lysozyme-galaetomannan conjugate. 
2.3. Preparation of lysozyme-palmitic acid conjugate 
Palmitic acid was esterified with N-hydroxysuccinimide as pre- 
viously reported [10]. The esterified fatty acid was covalently attached 
to a lysyl residue of lysozyme by base-catalyzed ester exchange ac- 
cording to the method of Haque et al. [10]. The degree of incorpora- 
tion was controlled by adjusting the molar ratio of N-hydroxysucci- 
nimide ester of fatty acid to lysozyme to obtain dipalmitoylated 
lysozyme [6]. 10 ml of tetrahydrofuran (THF) containing 1.4 mM 
N-hydroxysuccinimide ester of palmitic acid was gradually added to 
40 ml of 50 mM potassium phosphate buffer (pH 7.0) containing 0.7 
mM lysozyme. The pH was then brought o 9.0 with l N NaOH at 
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25°C. The reaction mixture was incubated for I h at 25°C with gentle 
agitation. The pH was then adjusted back to 7.0 with 1 N HCI, and 
the mixture was subsequently dialyzed for 2 days at 4°C against po- 
tassium phosphate buffer containing 1 M NaC1. Following dialysis, 
the reaction mixture was washed five times with ice-cold diethyl ether, 
dialyzed against deionized water for 3 days at 4°C and lyophilized. 
The resulting powder was stored at 4°C and used as lysozyme-palmitic 
acid conjugate. 
2.4. Measurement of lysozyme activity 
Lysozyme activity was measured by the lytic assay using M. lyso- 
deikticus cells as a substrate [11]. The lysis of cells in 50 mM potas- 
sium phosphate buffer (pH 7.0) was monitored at 660 nm. A 0.1 ml 
portion of the lysozyme conjugates solution (final lysozyme concen- 
tration, 0.003%) was added to 2.4 ml of M. lysodeikticus cell suspen- 
sion (final concentration, 250 mg/ml; dry weight in the same buffer). 
This lysis mixture gave an initial OD of 0.8-0.85 at the onset of the 
experiment. The initial velocities were determined by measuring the 
decrease in turbidity of the cells automatically monitored at 660 nm 
(25°C) using a Hitachi U-2000 recording spectrophotometer (Tokyo, 
Japan). 
2.5. Bacteria 
E. tarda NG8104, a virulent strain for fish, was obtained from Dr. 
T. Kitao, Miyazaki University, Japan. The strain was cultured on 
heart infusion agar for 24 h at 37°C and orally administered three 
times to carp to maximize its virulence [12]. 
2.6. Antibacterial ssays 
Overnight cultured E. tarda cells were harvested from the heart 
infusion broth by centrifugation and were resuspended in 50 mM 
potassium phosphate buffer (pH 7.0) after washing twice with the 
same buffer. Washed cell preparations were diluted with the same 
buffer to give a concentration of 105 cells/ml using a hematometer. 
The cell suspension was added to the cell suspension to give a final 
lysozyme concentration of 50 mg/ml. 5 ml of the suspension was 
incubated at 37°C in a water bath equipped with a Lab-thermoshaker 
(Advantec Co., Tokyo, Japan) at 90 rpm to provide constant em- 
perature and cell suspension. After a given incubation time, decimal 
dilution of the sample was subsequently carried out in physiological 
saline adjusted to pH 7.2. A 100 ml volume of cell suspension or 
dilution was spread onto two separate nutrient agar plates (MacCon- 
key). All plates were incubated at 350C for 24 h, and then the viable 
cell numbers were counted. Percentage of survivors was presented 
with respect o control mixture. The experiment was performed in 
triplicate. 
2.7. Fish 
Carp, Cyprinus carpio L., weighing 23.7 + 2.8 g were obtained from 
a fish farm in Kumamoto, Japan, and were acclimatized to laboratory 
conditions with a commercial fish pellet in a 50 1 aquarium at 22 + I°C 
for 2 weeks. 
2.8. Challenge test 
The fish were fed a pelleted food containing lysozyme conjugates at 
a daily ratio of 1.5% body weight at 10:00 h and 19:00 h for 8 days 
prior to challenge with E. tarda. Lysozyme conjugates were given to 
the fish at a dosage of 40 mg kg -1 day -1. Challenge was performed 
on the 8th day by intraperitoneal injection of 0.2 ml of bacterial 
suspension in physiological saline (1.9× 10 s CFU100 g-l). The fish 
were subsequently fed a commercial pellet to observe lysozyme con- 
jugates-induced protection of carp against he bacterial infection. 10 
fish per treatment were used in each experiment. Dead fish were im- 
mediately removed from the experimental quarium and survivors 
were recorded for 6 days. In a separate set of experiments, lysozyme 
conjugates were orally administered to the acclimatized carps 3 h 
before and 2 h after intraperitoneal challenge with 2.1×108 
CFU100 g-] of E. tarda, respectively. The fish were subsequently 
fed with a pelleted food containing lysozyme conjugates at a dosage 
of 40 mg kg 1 day-~ and survivors were recorded for 6 days in a 
similar manner to the above. In this study, the administered dosage 
and the dose of bacteria used to challenge the fish were determined 
according to a preliminary experiment and previous tudies on immu- 
nostimulation effect of polysaccharides [12,13]. 
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3. Results and discussion 
Maillard-type protein-polysaccharide conjugates are formed 
between the a- or e-amino groups in protein and the reducing- 
end carbonyl group in polysaccharide through Schiff base. 
Covalent attachment of lysozyme to galactomannan was con- 
firmed by SDS-slab polyacrylamide gel electrophoresis [5]. 
The binding molar ratio was calculated on the assumption 
that the molecular weight of lysozyme and galactomannan 
were 14000 and 15 000, respectively. About 2 molecules of 
galactomannan appeared to link to one molecule of lysozyme 
on the basis of the binding weight ratio. The measurement of
free amino groups in the conjugate were carried out to obtain 
further information on the binding. The results of the TNBS 
method demonstrated a decrease of 1.8 free amino groups per 
molecule in the conjugate. This result is consistent with the 
binding weight ratio described above. Diacylation of lysozyme 
with palmitic acid was adjusted by controlling the mole ratio 
of N-hydroxysuccinimide ester of the fatty acid to lysozyme 
molecules. The stoichiometry of acylation of the dipalmitoy- 
lated lysozyme was confirmed by measuring the TNBS-non- 
available free amino groups of the lysozyme conjugate which 
was 1.9 mol palmitic acid/mol of lysozyme. When the lytic 
activity of the conjugates was measured using M. lysodeikti- 
cus, lysozyme-galactomannan andlysozyme-palmitic a id con- 
jugate exhibited about 80 and 71% enzymatic activity of con- 
trol lysozyme, respectively. The observed decrease in residual 
activities of lysozyme conjugates may be attributed to the 
decrease in surface positive charge [14-16]. Modified lysozyme 
with approx. 2 molecules of polysaccharide or hydrocarbon 
chains per molecule of lysozyme maintained considerably high 
enzymatic activities. 
In order to assess the protective ffect of lysozyme conju- 
gates against E. tarda NG8104, the mid-logarithmic phase 
culture was mixed with lysozyme conjugates at 37°C, and 
viable cell numbers were determined using MacConkey agar 
plates. Fig. 1 shows antimicrobial effects of lysozyme-galacto- 
mannan and lysozyme-palmitic a id conjugates against E. tar- 
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Fig. 1. Bactericidal activity of native lysozyme and lysozyme conju- 
gates against E. tarda cells as a function of incubation time at 
37°C. 50 mg/ml native lysozyme ((>), lysozyme-galactomannan con-
jugate (0), or lysozyme-palmitic a id conjugate ($) were incubated 
with E. tarda cells (105 cells/ml) in 50 mM potassium phosphate 
buffer, pH 7.0. Values are means of three independent experiments, 
and the bars indicate the standard eviation. 
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Fg. 2. Protective ffect of lysozyme conjugates administered to carp 
challenged with E. tarda (1.9× 108 CFU100 g-l). Lysozyme conju- 
gztes were given at a dosage of 40 mg kg -1 day -1 for 8 days prior 
tv challenge. N = 10 per group. ( zx ) Native lysozyme, (• )  lysozyme- 
g~dactomannan conjugate, (0) galactomannan conjugate, (e) lyso- 
z x me-palmitic acid conjugate, (©) palmitic acid, (• )  control without 
te~ted material. Data are from a representative experiment repeated 
tl-ree times with similar results. 
d,t as a function of incubation time. A significant decrease in 
tl~e viable cell numbers was observed in the incubation med- 
item containing lysozyme-palmitic acid conjugate. The antimi- 
c~ obial effect of the palmitoylated lysozyme on E. tarda was 
similar to the bactericidal ction against Esoherichia coli that 
as previously reported by Ibrahim et al. [6]. Lysozyme-ga- 
lactomannan conjugate exhibited remarkable antimicrobial 
a,;tivity but was less effective than palmitoylated lysozyme 
(Fig. 1). It seems to be related to the evidence that polygly- 
c,)sylated lysozyme could be lethal to Gram-negative bacteria 
ilcluding Enterobacteriaceae following incubation at 50°C, 
bat could not be as lethal following incubation at 20°C [5]. 
I1~ addition, to verify the specific role of lysozyme in the con- 
jt~gates, we used a-lactalbumin as a conjugate protein control, 
x~ hich has a close structural similarity to hen egg-white lyso- 
z:..'me [17]. a-Lactalbumin conjugates did not exhibit any anti- 
nicrobial activities against E. tarda (data not shown). Thus, it 
c,)uld be demonstrated that lysozyme plays an important role 
t,, act as an antimicrobial gent in the conjugates. 
Lysozyme conjugates were given at a dosage of 40 mg kg -1 
dty -1 for 8 days prior to challenge. On day 8, the fish were 
cilallenged with E. tarda and survivors was monitored for 6 
dlys. As shown in Fig. 2, oral administration of lysozyme 
c,mjugates to carp enhanced protection against E. tarda 
s rain. The survival rate was 30% for lysozyme-galactoman- 
n m conjugate treated fish and 20% for lysozyme-palmitic a id 
c mjugate treated fish after 6 days cultivation, while all control 
fi ~h died within 3 days. Recently, the administration of some 
polysaccharides was reported to enhance protection of fish 
against bacterial infection as immunostimulants [12,13]. In 
mammals, polysaccharides potentiate the non-specific immune 
responses, such as activation of macrophages, NK cells, T- 
l xmphocytes and interferon products, and that their activities 
are associated with the activation of the alternative comple- 
ment pathway [18-20]. Fish given galactomannan without ly- 
sozyme had a survival rate of 20% 6 days after the challenge, 
whereas there were no survivors in the group fed palmitic acid 
only. The protective ffect of lysozyme-galactomannan on 
carp may indicate that polysaccharide moiety of the conjugate 
stimulated the non-specific immune system of the host fish in 
addition to the bactericidal ctivity of lysozyme moiety. The 
therapeutic effect of galactomannan has been also anticipated 
to be important in overcoming bacterial infection. Yamamoto 
et al. [21] reported that oral administration of galactomannan 
reduced total contents of lipids in rat livers. 
The survival rate of carp infected with E. tarda (2.1 × 108 
CFU100 g- l )  was also monitored to investigate the effects of 
the conjugates on fish recovery. Lysozyme conjugates were 
orally administered to the test carp 3 h before and 2 h after 
intraperitoneal challenge with E. tarda. The fish were subse- 
quently fed a pelleted food containing lysozyme conjugates at 
a dosage of 40 mg kg -1 day -1. As shown in Fig. 3, fish fed 
lysozyme-palmitic a id conjugate had a significantly greater 
survival rate than fish fed native or lysozyme-galactomannan 
conjugate. The survival rate of infected fish was 40% for ly- 
sozyme-palmitic a id conjugate group after 6 days while all 
control fish died within 3 days. Fish fed lysozyme-galacto- 
mannan conjugate or native lysozyme had a 20% survival 
rate. In the same experimental system, any survival effect of 
galactomannan was not observed. All fish fed galactomannan 
died within 3 days. The higher survival rate of palmitoylated 
lysozyme compared to polyglycosylated lysozyme was com- 
patible with the differences in bactericidal activities between 
palmitic acid conjugate and galactomannan conjugate. It is 
well known that in vivo modification of proteins by fatty acids 
such as myristic, palmitic and stearic acids, is a widespread 
behavior of protein anchoring and fusion into membranes 
[22]. Attachment of fatty acids to lysozyme is important for 
its bactericidal effect against E. tarda by interaction with and 
subsequent insertion into the outer membrane of Gram-nega- 
tive bacteria. Fatty acylation of lysozyme have been regarded 
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Fig. 3. Recovery of carp challenged with E. tarda (2.1×108 
CFU100 g-l). Lysozyme conjugates were given at a dosage of 40 
mg kg -1 day -1 with commercial fish pellet for 6 days after chal- 
lenge with E. tarda. N= l0 per group. (zx) Native lysozyme, (~) ly- 
sozyme-galactomannan co jugate, (~)) galactomannan conjugate, 
(e) lysozyme-palmitic a id conjugate, (©) palmitic acid, (• )  control 
without tested material. Data are from a representative experiment 
repeated three times with similar results. 
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as directly mediating the interaction and penetration of lyso- 
zyme into the membrane to perform its action on the pepti- 
doglycan of Gram-negative bacteria [7]. Although antimicro- 
bial drugs have been employed for prophylactic and 
therapeutic purposes, recent occurrence of drug-resistant 
strains has made treatment with antibiotics more difficult. 
Lysozyme-palmitic a id conjugate may provide a safe alterna- 
tive for the prevention of E. tarda infection in farmed fish. 
The development of lysozyme-galactomannan conjugate con- 
taining palmitic acid chain as a mean of improving the bac- 
tericidal activity of lysozyme-galactomannan conjugate is in 
progress. 
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